Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016053 (
fibromyalgia
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fibromyalgia
typically presents with spontaneous body pain with no apparent cause and is considered pathophysiologically to be a functional disorder of somatosensory processing. We have investigated potential associations between the degree of self-reported clinical pain and resting-state brain functional connectivity at different levels of putative somatosensory integration. Resting-state functional magnetic resonance imaging was obtained in 40 women with
fibromyalgia
and 36 control subjects. A combination of functional connectivity-based measurements were used to assess (1) the basic pain signal modulation system at the level of the periaqueductal gray (PAG); (2) the sensory cortex with an emphasis on the parietal operculum/secondary somatosensory cortex (
SII
); and (3) the connectivity of these regions with the self-referential "default mode" network. Compared with control subjects, a reduction of functional connectivity was identified across the 3 levels of neural processing, each showing a significant and complementary correlation with the degree of clinical pain. Specifically, self-reported pain in
fibromyalgia
patients correlated with (1) reduced connectivity between PAG and anterior insula; (2) reduced connectivity between
SII
and primary somatosensory, visual, and auditory cortices; and (3) increased connectivity between
SII
and the default mode network. The results confirm previous research demonstrating abnormal functional connectivity in
fibromyalgia
and show that alterations at different levels of sensory processing may contribute to account for clinical pain. Importantly, reduced functional connectivity extended beyond the somatosensory domain and implicated visual and auditory sensory modalities. Overall, this study suggests that a general weakening of sensory integration underlies clinical pain in
fibromyalgia
.
...
PMID:The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia. 2479 77
Fibromyalgia
is a chronic pain syndrome, characterized by widespread musculoskeletal pain with diffuse tenderness at multiple tender points. Despite intense investigations, the pathophysiology of
fibromyalgia
remains elusive. Evidence shows that it could be due to changes in either the peripheral or central nervous system (CNS). For the CNS changes, alterations in the high brain area of
fibromyalgia
patients have been investigated but the definite mechanisms are still unclear. Magnetic Resonance Imaging (MRI) and Functional Magnetic Resonance (fMRI) have been used to gather evidence regarding the changes of brain morphologies and activities in
fibromyalgia
patients. Nevertheless, due to few studies, limited knowledge for alterations in brain activities in
fibromyalgia
is currently available. In this review, the changes in brain activity in various brain areas obtained from reports in
fibromyalgia
patients are comprehensively summarized. Changes of the grey matter in multiple regions such as the superior temporal gyrus, posterior thalamus, amygdala, basal ganglia, cerebellum, cingulate cortex,
SII
, caudate and putamen from the MRI as well as the increase of brain activities in the cerebellum, prefrontal cortex, anterior cingulate cortex, thalamus, somatosensory cortex, insula in fMRI studies are presented and discussed. Moreover, evidence from pharmacological interventions offering benefits for
fibromyalgia
patients by reducing brain activity is presented. Because of limited knowledge regarding the roles of brain activity alterations in
fibromyalgia
, this summarized review will encourage more future studies to elucidate the underlying mechanisms involved in the brains of these patients.
...
PMID:Alterations of brain activity in fibromyalgia patients. 2808 91